XIAOMI-W
01810
BABA-W
09988
ALI HEALTH
00241
KUAISHOU-W
01024
BIDU-SW
09888
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | 15.97%-205.59M | 18.70%-350.98M | -6.47%-244.65M | 16.56%-431.69M | -52.96%-229.78M | -83.53%-517.36M | 4.95%-150.22M | -147.95%-281.9M | -331.60%-158.05M | -600.84%-113.69M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | ---- | ---- | ---- | -321.34%-3.22M | 35.20%-2.79M | 73.38%-764K | 48.53%-4.3M | 46.76%-2.87M | 16.53%-8.35M |
Investment loss (gain) | ---- | ---- | ---- | ---- | 44.08%-1.15M | -1.62%-3.77M | -42.86%-2.06M | ---3.71M | -624.36%-1.44M | ---- |
Attributable subsidiary (profit) loss | 448.26%1.26M | 5,025.93%1.38M | --230K | --27K | ---- | ---- | ---- | 94.48%599K | 125.90%314K | 53.23%308K |
Impairment and provisions: | 326.90%50.1M | 73.72%29.04M | 2,529.81%11.74M | 306.12%16.72M | -127.71%-483K | 5.95%4.12M | 402.60%1.74M | 36.65%3.89M | -166.28%-576K | 108.28%2.84M |
-Impairmen of inventory (reversal) | -6.52%8.76M | 208.34%12.6M | 564.27%9.37M | 62.76%4.09M | -686.63%-2.02M | 954.08%2.51M | 340.56%344K | -129.64%-294K | -146.13%-143K | 155.67%992K |
-Impairment of trade receivables (reversal) | 63.20%3.86M | 314.76%4.78M | 54.20%2.37M | 24.14%1.15M | 24.70%1.54M | 244.10%928K | 384.30%1.23M | -134.79%-644K | -177.46%-433K | 89.46%1.85M |
-Impairment of goodwill | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.26M | ---- | ---- |
-Other impairments and provisions | --37.48M | 1.59%11.66M | ---- | 1,595.27%11.48M | ---- | -80.98%677K | --168K | --3.56M | ---- | ---- |
Revaluation surplus: | 215.56%111.79M | -203.33%-45.88M | -31.79%35.43M | -110.90%-15.13M | 4,455.44%51.93M | 78.87%138.73M | -98.59%1.14M | 7,550.34%77.56M | 94,864.71%80.72M | 19.61%-1.04M |
-Other fair value changes | 215.56%111.79M | -203.33%-45.88M | -31.79%35.43M | -110.90%-15.13M | 4,455.44%51.93M | 78.87%138.73M | -98.59%1.14M | 7,550.34%77.56M | 94,864.71%80.72M | 19.61%-1.04M |
Asset sale loss (gain): | 19.44%516K | -10.49%691K | 374.73%432K | -15.54%772K | -90.23%91K | -17.51%914K | 3.33%931K | 624.18%1.11M | 923.86%901K | 750.00%153K |
-Loss (gain) on sale of property, machinery and equipment | 19.44%516K | -10.49%691K | 374.73%432K | -15.54%772K | -90.23%91K | -17.51%914K | 3.33%931K | 624.18%1.11M | 923.86%901K | 750.00%153K |
Depreciation and amortization: | 13.44%40.3M | 15.25%74.05M | 18.33%35.52M | 34.47%64.25M | 30.49%30.02M | 45.25%47.78M | 63.72%23.01M | 59.36%32.9M | 53.96%14.05M | 59.59%20.64M |
-Amortization of intangible assets | 12.94%2.51M | -16.37%4.53M | -1.68%2.23M | 39.83%5.42M | 23.93%2.26M | 31.95%3.87M | 43.44%1.83M | 62.84%2.94M | 43.03%1.27M | 13.97%1.8M |
Financial expense | 14.15%14.23M | 107.33%27.51M | 277.32%12.46M | 457.99%13.27M | 189.23%3.3M | -56.22%2.38M | -74.68%1.14M | 595.52%5.43M | 1,065.37%4.51M | 1,401.92%781K |
Exchange Loss (gain) | -1,451.41%-62.11M | 559.24%25.68M | -35.53%4.6M | -62.05%3.9M | 137.55%7.13M | 15.48%10.27M | 338.74%3M | 345.40%8.89M | ---1.26M | 8.49%-3.62M |
Special items | -199.28%-11.87M | -126.79%-14.48M | -66.65%11.95M | 38.35%54.07M | 155.64%35.85M | 125.30%39.08M | 92.03%14.02M | 60.89%17.35M | 35.85%7.3M | 21.80%10.78M |
Operating profit before the change of operating capital | 53.60%-61.38M | 13.90%-252.99M | -24.44%-132.3M | -4.69%-293.82M | 1.62%-106.31M | -97.38%-280.65M | -91.62%-108.06M | -55.92%-142.19M | -119.73%-56.39M | -395.47%-91.2M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | -424.13%-4.92M | 79.88%-3.93M | 110.69%1.52M | -29.01%-19.53M | -307.29%-14.19M | -1.14%-15.14M | 16.63%-3.49M | -77.77%-14.97M | -60.46%-4.18M | -55.83%-8.42M |
Accounts receivable (increase)decrease | 372.08%83.29M | -407.33%-116.99M | -179.57%-30.61M | 2,326.13%38.07M | -19.66%38.47M | 102.24%1.57M | 553.35%47.88M | -397.89%-69.91M | -59.07%7.33M | -106.63%-14.04M |
Accounts payable increase (decrease) | 297.57%64.63M | -127.72%-57.31M | -155.11%-32.71M | 25.81%206.7M | 180.06%59.36M | 243.69%164.29M | 253.05%21.19M | -50.34%47.8M | -97.21%-13.85M | 1,563.38%96.26M |
prepayments (increase)decrease | -166.78%-26.74M | 81.32%-11.16M | 70.27%-10.02M | -543.95%-59.74M | -1,332.87%-33.72M | -648.75%-9.28M | -79.54%2.74M | 77.79%-1.24M | 394.58%13.37M | 8.57%-5.58M |
Special items for working capital changes | -549.17%-3.14M | 10,049.13%102.48M | 94.96%-484K | -186.19%-1.03M | -441.12%-9.6M | -94.53%1.2M | 5,216.36%2.81M | 19,765.77%21.83M | 99.96%-55K | -100.16%-111K |
Cash from business operations | 125.29%51.74M | -162.77%-339.9M | -210.04%-204.61M | 6.27%-129.35M | -78.75%-66M | 13.02%-138.01M | 31.35%-36.92M | -587.39%-158.67M | 64.27%-53.78M | -107.55%-23.08M |
Other taxs | -256.80%-9.23M | -503.18%-2.66M | -227.24%-2.59M | 192.83%660K | 1,238.16%2.03M | -115.71%-711K | 100.86%152K | 124.04%4.53M | -47.42%-17.78M | -871.07%-18.83M |
Interest received - operating | 81.07%39.12M | 463.52%58.83M | 799.92%21.61M | 198.12%10.44M | 16.16%2.4M | -20.08%3.5M | -30.80%2.07M | -65.47%4.38M | -68.23%2.99M | 215.93%12.69M |
Interest paid - operating | -12.63%-1.78M | -56.20%-3.19M | -260.64%-1.58M | -29.38%-2.04M | 62.07%-437K | -18.50%-1.58M | -103.89%-1.15M | -81.20%-1.33M | -391.30%-565K | -1,397.96%-734K |
Net cash from operations | 142.66%79.86M | -138.51%-286.91M | -201.90%-187.17M | 12.06%-120.29M | -72.92%-62M | 9.47%-136.79M | 48.14%-35.85M | -404.40%-151.09M | 54.90%-69.14M | -109.74%-29.96M |
Cash flow from investment activities | ||||||||||
Restricted cash (increase) decrease | 181.82%450K | -40.95%-5.06M | ---550K | -226.32%-3.59M | ---- | 226.09%2.84M | 196.82%2.1M | -119.24%-2.25M | ---2.17M | --11.72M |
Loan receivable (increase) decrease | ---- | ---- | ---- | 347.96%1.43M | 380.88%1.53M | 176.87%319K | 250.47%319K | 79.32%-415K | ---212K | ---2.01M |
Decrease in deposits (increase) | -248.26%-944.06M | -439.70%-174.45M | -1.00%-271.08M | 44.68%-32.32M | -247.91%-268.4M | -569.39%-58.43M | -214.04%-77.15M | 108.37%12.45M | ---24.57M | -1,109.28%-148.69M |
Sale of fixed assets | --69K | 175.00%242K | ---- | -67.65%88K | -24.17%160K | 385.71%272K | 1,072.22%211K | -84.62%56K | 1,700.00%18K | --364K |
Purchase of fixed assets | -25.11%-100.33M | 23.67%-153.66M | -8.48%-80.2M | -53.27%-201.3M | -7.52%-73.93M | -7.76%-131.34M | -18.26%-68.76M | -10.43%-121.88M | -7.99%-58.14M | -55.81%-110.37M |
Purchase of intangible assets | 87.54%-112K | -78.54%-4.05M | 89.54%-899K | 47.88%-2.27M | -224.05%-8.6M | 25.82%-4.35M | -10.13%-2.65M | -337.58%-5.87M | -1,317.06%-2.41M | -101.35%-1.34M |
Sale of subsidiaries | ---- | ---- | ---- | --201K | ---- | ---- | ---- | ---- | ---- | ---- |
Recovery of cash from investments | 705.37%165.87M | 39.87%258.2M | -86.76%20.6M | -24.34%184.61M | 114.38%155.49M | -45.85%243.98M | -70.14%72.53M | -63.43%450.54M | -68.28%242.89M | 148,344.10%1.23B |
Cash on investment | -108.26%-254.93M | 28.50%-278.95M | 14.48%-122.41M | -46.75%-390.13M | -49.84%-143.13M | 38.58%-265.84M | 64.26%-95.53M | 63.64%-432.79M | 65.37%-267.29M | -1,300.62%-1.19B |
Net cash from investment operations | -149.27%-1.13B | 19.30%-357.73M | -34.93%-454.54M | -108.56%-443.3M | -99.43%-336.87M | -112.20%-212.55M | -50.99%-168.92M | 51.99%-100.17M | -86.03%-111.87M | -7.56%-208.63M |
Net cash before financing | -64.12%-1.05B | -14.38%-644.64M | -60.88%-641.71M | -61.33%-563.59M | -94.79%-398.87M | -39.04%-349.34M | -13.13%-204.77M | -5.31%-251.26M | 15.19%-181.01M | -309.85%-238.59M |
Cash flow from financing activities | ||||||||||
New borrowing | 104.99%25.16M | 125.00%74.39M | 90.19%12.27M | 26.96%33.06M | -75.22%6.45M | -50.79%26.04M | -45.75%26.04M | 94.22%52.92M | 147.73%48.01M | 159.46%27.25M |
Refund | -358.62%-43.19M | -5,214.47%-24.61M | -3,697.58%-9.42M | 99.35%-463K | 99.52%-248K | -147.97%-71.22M | -209.76%-51.41M | -51.21%-28.72M | -55.29%-16.6M | ---18.99M |
Issuing shares | -99.57%4.39M | 143.36%1.03B | 21,343.41%1.02B | -54.55%423.31M | -99.15%4.77M | 52.54%931.34M | -8.85%560.8M | --610.54M | 30,119.84%615.28M | ---- |
Dividends paid - financing | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---6.53M | ---- | ---- |
Absorb investment income | ---- | -96.40%139K | ---- | --3.87M | ---- | ---- | ---- | ---- | ---- | ---- |
Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -54.03%-11.97M | -327.56%-9.71M | 32.25%-7.77M |
Other items of the financing business | --23.44M | 92.92%-2.38M | ---- | -270.25%-33.53M | ---- | 99.99%19.7M | ---- | 633.19%9.85M | 106.87%367K | -142.72%-1.85M |
Net cash from financing operations | -99.45%5.57M | 154.76%1.07B | 12,296.93%1.02B | -53.52%419.32M | -98.46%8.23M | 44.53%902.14M | -16.23%532.99M | 22,569.51%624.2M | 25,545.30%636.26M | -101.08%-2.78M |
Effect of rate | 110.62%528K | 90.42%-1.22M | 38.48%-4.97M | -1,327.08%-12.7M | -2,456.85%-8.08M | -123.94%-890K | 135.84%343K | 567.55%3.72M | -4,457.14%-957K | -150.00%-795K |
Net Cash | -376.93%-1.05B | 393.63%423.62M | 196.84%378.31M | -126.10%-144.27M | -219.02%-390.64M | 48.23%552.8M | -27.91%328.21M | 254.51%372.94M | 315.80%455.25M | -165.05%-241.37M |
Begining period cash | 41.25%1.45B | -13.29%1.02B | -13.29%1.02B | 87.74%1.18B | 87.74%1.18B | 149.23%629.06M | 149.23%629.06M | -48.97%252.4M | -48.97%252.4M | 299.30%494.56M |
Cash at the end | -71.42%399.3M | 41.25%1.45B | 78.63%1.4B | -13.29%1.02B | -18.31%782.25M | 87.74%1.18B | 35.51%957.62M | 149.23%629.06M | 149.20%706.69M | -48.97%252.4M |
Cash balance analysis | ||||||||||
Cash and bank balance | ---- | ---- | ---- | ---- | ---- | --966.66M | ---- | ---- | ---- | ---- |
Cash and cash equivalent balance | ---- | ---- | ---- | ---- | ---- | --966.66M | ---- | ---- | ---- | ---- |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- | -- | -- | -- | Unqualified Opinion |
Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.